Search Results 1401-1410 of 20004 for Hepatitis b

  1. Liver transplant - Doctors & Departments - Mayo Clinic

    Hepatitis B · Hepatitis C · Hepatocellular carcinoma (HCC) · Hilar cholangiocarcinoma · Liver cancer · Liver disease · Liver hemangioma · Living-donor liver ...

  2. Liver transplant - Doctors & Departments - Mayo Clinic

    Autoimmune hepatitis · Cholangiocarcinoma (bile duct cancer) · Cirrhosis · Esophageal varices · Hepatic encephalopathy · Hepatitis B · Hepatitis C ...

  3. MEDI5395 Advanced Solid Tumors - Clinical Trials

    Positive hepatitis A immunoglobulin M;; Positive hepatitis B surface antigen or positive hepatitis B core antibody, with the exception of subjects who are ...

  4. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

    Must be tested for hepatitis B surface antigen (HBsAg) and total hepatitis B core antibody (anti-HBc) within 2 weeks of registration. Patients who are ...

  5. Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis - Mayo Clinic

    of spirits/hard liquor). 2. History or presence of other concomitant liver diseases at screening: 1. Chronic hepatitis B or C virus (HBV, HCV) infection.

  6. Liver transplant - Doctors & Departments - Mayo Clinic

    Hepatitis B · Hepatitis C · Hepatocellular carcinoma (HCC) · Hilar cholangiocarcinoma · Liver cancer · Liver disease · Liver hemangioma · Living-donor liver ...

  7. Liver transplant - Doctors & Departments - Mayo Clinic

    Hepatitis B · Hepatitis C · Hepatocellular carcinoma (HCC) · Hilar cholangiocarcinoma · Liver cancer · Liver disease · Liver hemangioma · Living-donor liver ...

  8. Testing The Addition Of Paclitaxel Administered Into The Abdominal Cavity Combined With Chemotherapy For Patients With Gastric Cancer Spread To The Abdominal Cavity - Mayo Clinic

    * For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated * ...

  9. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

    Positive hepatitis B (hepatitis B surface antigen and antibody) and/or hepatitis C (hepatitis C antibody test) as indicated by serologies conducted =< 3 ...

  10. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

    Positive test results for hepatitis B core antibody (HBcAb) or hepatitis C virus (HCV) antibody at screening: Patients who are positive for HCV antibody ...